


膣薬物送達の イノベーター
反復流産の
— As featured in —

患者アウトカムを 改善するには、 新しく 革新的な 女性専用の 薬物送達システムが 必要
詳細を
Calla Lily Clinical Careは、 注目に 値するいくつかの 利点を 備えた 新しい 膣薬物送達デバイスの 特許を 取得
詳細を
“Callavid will be unbelievably popular with miscarriage patients as pessary leakage is the most frequent complaint, causing significant anxiety. The benefits of reducing psychological trauma, anxiety and depression are badly needed.”
Professor Siobhan Quenby
Director Biomedical Research Unit in Reproductive Health,Professor of Obstetrics University of Warwick,
Deputy Director Tommy’s National Centre for Miscarriage Research,
Calla Lily Clinical Care Medical Advisor
Issue 394, Summer 2023
The vagina’s huge medical potential has gone untapped, but not for much longer
“Calla Lily has developed a new leak-free vaginal drug delivery platform. It's simple to use (essential when patients have to administer medications themselves) and also helps to alleviate dosage anxiety and other stresses”

“NICEの 新しい 流産管理の ガイダンスの おかげで、 流産発生率の 減少に 役立つ 処方薬と して 初の 推奨薬、 微粉化膣プロゲステロンが できました。 Calla Lily Clinical Careの 新しい デバイスは、 漏れや 経膣的に 送達される プロゲステロン関連の これまでの 不便さの 問題に 対処しています。 ”
Stuart Lavery博士
(UCLHの
“This novel platform is of great benefit to anyone using a vaginally-delivered medication. By addressing the major issue of leakage, women can be assured the device delivers the correct dose in a convenient, tidy and less invasive fashion. It is truly a transformative device.”
Dr Kelle Moley
Former Deputy Director of Reproductive Health Technologiesat the Bill & Melinda Gates Foundation,
Calla Lily Clinical Care Medical Advisor